Navigation Links
Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
Date:7/23/2009

SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report second quarter 2009 financial results on Thursday, July 30, 2009, after the U.S. financial markets close.

Anadys will hold a conference call and webcast on Thursday, July 30, 2009 at 5:00 p.m. Eastern Daylight Time to discuss its second quarter 2009 financial results and highlights and to provide an update on its development programs. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 85411914. The webcast and telephone replay will be available through August 13, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines. The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... de julio de 2014 ADB International ... ha anunciado hoy una asociación con Austen BioInnovation ... o el Instituto), para el propósito de llevar ... terapia de señal bioeléctrica (el E-QURE BST Device), ... que tiene una importante experiencia en cicatrización de ...
(Date:7/23/2014)... July 23, 2014 regulated information -- UCB today ... development pipeline with positive topline results from the ... study was designed to evaluate the efficacy and ... mg/day, without titration) compared to placebo, as adjunctive ... seizures, not fully controlled despite treatment with one ...
(Date:7/23/2014)... With the ability to record continuously at over ... 15 minutes, Fastec Imaging has brought the same ease-of-use of ... “Finally, a high speed camera that can be used as ... lives.” proclaims Matt Kearney, VP of Sales for Fastec Imaging. ... and simplify the traditionally complicated workflow of a high speed ...
(Date:7/22/2014)... 2014 (PRWEB) July 23, 2014 ... University. , The goal of the Symposium ... full spectrum of scientists working in the biomaterials ... topics that represent the most promising directions for ...     Provide faculty and government scientists ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2
... , Madison, Wis. Battery and household products manufacturer ... St. Louis-based firm United Industries for $1.2 billion dollars of ... in February. The deal will give Rayovac an increased foothold ... such as Spectracide, Vigoro and Sta-Green. , Inacom joins EMC ...
... Spence, a physics graduate student, and Roch Kendrick, a ... clothing while working on equipment used for the Madison ... Photo courtesy of UW-Madison. In an underground bunker ... side, and a cornfield on the other, a team ...
... satellite. Courtesy of UW-Madison. Madison, Wis. ... the University of Wisconsin's Cooperative Institute for Meteorological ... institute has begun testing its weather forecast data using ... Silicon Graphics Inc. , a company headquartered in California ...
Cached Biology Technology:Tech Digest: Rayovac, Inacom, TomoTherapy, Regal-Beloit, Modine 2Earth's core modeled in underground experiment 2Earth's core modeled in underground experiment 3UW-Madison picks scalable SGI computer to simulate weather 2UW-Madison picks scalable SGI computer to simulate weather 3
(Date:7/23/2014)... disease, the devastating neurological disease affecting more than ... new progress on a set of compounds, initially ... a potential oral therapy for Alzheimer,s. Their study ... . , Carlo Ballatore, Kurt R. Brunden and ... protein known as tau binds to and stabilizes ...
(Date:7/23/2014)... and blood-brain barrier damage appear after cerebral ... Matrix metalloproteinase-9 is able to degrade the ... cerebral blood vessels and to mediate extracellular ... colleagues from the First Affiliated Hospital of ... induced cerebral infarction in stroke-prone spontaneously hypertensive ...
(Date:7/23/2014)... is available in German . ... Max Planck Institute of Molecular Cell Biology and ... capture detailed three-dimensional images of cardiac dynamics in ... Plane Illumination Microscopy (SPIM) and clever image processing ... heart. Furthermore, they have developed a method of ...
Breaking Biology News(10 mins):Unbreak my heart 2
... sequence the genome of a microbiological master of ... scientists because they are able to live under ... concentrations, high pH-values, or high temperatures. Nature's masters ... researchers can draw conclusions about the first organisms ...
... Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute ... have now added key evidence to claims that some types ... reported this week in the on-line edition of Nature ... placed in the right locations within stem cells before they ...
... melanoma this year, says the American Cancer Society, and ... caught in the early stages, melanoma can be a ... with an efficiency that few tumors possess. Now, researchers ... of the reasons why this particular skin tumor is ...
Cached Biology News:Life in deadly conditions 2Life in deadly conditions 3A new link between stem cells and tumors 2Researchers discover why melanoma is so malignant 2Researchers discover why melanoma is so malignant 3